Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report)’s share price dropped 12.4% during trading on Monday . The company traded as low as GBX 1.53 ($0.02) and last traded at GBX 1.53 ($0.02). Approximately 1,131,357 shares were traded during mid-day trading, a decline of 4% from the average daily volume of 1,177,392 shares. The stock had previously closed at GBX 1.75 ($0.02).
Cizzle Biotechnology Stock Performance
The stock has a market cap of £6.34 million, a PE ratio of -160.00 and a beta of 0.38. The business’s fifty day moving average price is GBX 1.89 and its 200-day moving average price is GBX 1.85.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Recommended Stories
- Five stocks we like better than Cizzle Biotechnology
- Following Congress Stock Trades
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- What Makes a Stock a Good Dividend Stock?
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
